Oreste Villani

Azacitidine for the treatment of lower risk myelodysplastic syndromes

Pellegrino Musto, Luca Maurillo, Alessandra Spagnoli et al. · Cancer · 2010 · 104 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +8

Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study

Giovanni D’Arena, Paolo G. Gobbi, Chiara Broglia et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2011 · 101 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

MicroRNA-155 in serum-derived extracellular vesicles as a potential biomarker for hematologic malignancies - a short report

Antonella Caivano, Francesco La Rocca, Vittorio Simeon et al. · Cellular Oncology · 2016 · 84 citations · Full text

Medicine, Hematology, Oncology +16

Frontline chemotherapy with bortezomib-containing combinations improves response rate and survival in primary plasma cell leukemia: a retrospective study from GIMEMA Multiple Myeloma Working Party

Giovanni D’Arena, Caterina Giovanna Valentini, Giuseppe Pietrantuono et al. · Annals of Oncology · 2011 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

Rituximab for warm‐type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients

Giovanni D’Arena, Catello Califano, Mario Annunziata et al. · European Journal Of Haematology · 2007 · 71 citations

Life Sciences, Hematology, Immunology +17